(Q50777216)

19 March 2018

title

Could a federal program to promote influenza vaccination among elders be cost-effective? (English)

1 reference

19 March 2018

author name string

Mitesh S Patel

series ordinal

1

1 reference

19 March 2018

Matthew M Davis

series ordinal

2

1 reference

19 March 2018

language of work or name

English

0 references

publication date

15 February 2006

1 reference

19 March 2018

published in

Preventive Medicine

1 reference

19 March 2018

volume

42

1 reference

19 March 2018

issue

3

1 reference

19 March 2018

page(s)

240-246

1 reference

19 March 2018

Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults11The names and affiliations of the Task Force members are listed on page v of this supplement and at http://www.thecommunityguide.org22So

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.12.004

Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.12.004

Direct-to-consumer promotion of prescription drugs. Economic implications for patients, payers and providers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.12.004

The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.12.004

The causes of racial and ethnic differences in influenza vaccination rates among elderly Medicare beneficiaries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.12.004

Direct-to-consumer advertising: a haphazard approach to health promotion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.12.004

Direct-to-consumer prescription drug advertising builds bridges between patients and physicians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.12.004

Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.12.004

The number needed to vaccinate (NNV) and population extensions of the NNV: comparison of influenza and pneumococcal vaccine programmes for people aged 65 years and over

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.12.004

Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.12.004

An assessment of clinically useful measures of the consequences of treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.12.004

Influenza vaccination among minority populations in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.12.004

The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.12.004

Generalist and subspecialist physicians' knowledge, attitudes, and practices regarding influenza and pneumococcal vaccinations for elderly and other high-risk patients: a nationwide survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.12.004

The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.12.004

Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.12.004

Racial and ethnic disparities in influenza vaccination among elderly adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.12.004

Direct-to-consumer pharmaceutical advertising: physician and public opinion and potential effects on the physician-patient relationship.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.12.004

Impact of influenza vaccination on seasonal mortality in the US elderly population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.12.004

Mortality associated with influenza and respiratory syncytial virus in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.12.004

A 3-stage model for assessing the probable economic effects of direct-to-consumer advertising of pharmaceuticals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.12.004

A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.12.004

What affects influenza vaccination rates among older patients? An analysis from inner-city, suburban, rural, and Veterans Affairs practices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.12.004

10.1016/J.YPMED.2005.12.004

7 January 2021

Identifiers

DOI

1 reference

19 March 2018

1 reference

19 March 2018